NRP1 and neoplasm: Given the fact that the expression or elevation of integrin αvβ3 and neuropilin-1 are only restricted to tumors [9], [27], [28], we propose a strategy to improve the targeted delivery of Tα1 to tumor cells by adding the iRGD fragment to the C-terminus of Tα1.